Zobrazeno 1 - 10
of 13
pro vyhledávání: '"63"'
Autor:
Mohammad Shenasa, Markku Mäkijärvi, X. Chen, Michael Block, Dirk Böcker, Martin Borggrefe, A. Martinez-Rubio, S. Willems, Wilhelm Haverkamp, G. Breithardt, G. Hindricks
Publikováno v:
European Heart Journal. 15:76-82
The role of programmed ventricular stimulation (PVS) in patients at high risk of sudden death related to idiopathic dilated cardiomyopathy (DCM) is still controversial. The possible reason is that most study series have been too small or that only a
Autor:
Steffen Gloekler, Pascal Meier, Christian Seiler, Etienne Delacrétaz, Stefano F. de Marchi, Rainer Zbinden
Publikováno v:
Meier, Pascal; Glökler, Steffen; de Marchi, Stefano; Zbinden, Rainer; Delacrétaz, Etienne; Seiler, Christian (2010). An indicator of sudden cardiac death during brief coronary occlusion: electrocardiogram QT time and the role of collaterals. European Heart Journal, 31(10), pp. 1197-1204. Oxford: Oxford University Press 10.1093/eurheartj/ehp576
Aims The coronary collateral circulation has a beneficial role regarding all-cause and cardiac mortality. Hitherto, the underlying mechanism has not been clarified. The aim of this prospective study was to assess the effect of the coronary collateral
Autor:
Allan L. Klein, Linda Pape, Elizabeth A. Lieber, Marcus F. Stoddard, William E. Katz, Susan E. Jasper, Carolyn Apperson-Hansen, Joseph F. Malouf
Publikováno v:
European Heart Journal. 27:2858-2865
Aims To compare the feasibility and safety of transoesophageal echocardiograpy-guided cardioversion (CV) with enoxaparin and unfractionated heparin (UFH) in patients with atrial fibrillation (AF). Methods and results The Assessment of Cardioversion U
Autor:
Johan E.P. Waktare, Leif Sörnmo, Fredrik Holmqvist, S. Bertil Olsson, Carl Meurling, Martin Stridh
Publikováno v:
European Heart Journal. 27:2201-2207
The study set out to explore whether an index of atrial electrical electrophysiology can be used to predict atrial fibrillation (AF) relapse, and if the predictive properties differ as a result of arrhythmia duration. METHODS AND RESULTS: The study c
Autor:
Dimitrios Th. Kremastinos, George Karatasakis, Elias Tsougos, Ioannis Malakos, Nikolaos Dagres, Themistoclis Maounis, Fotios Panou, Dennis V. Cokkinos, G. Athanassopoulos, Kallirrhoe Kourea
Publikováno v:
European Heart Journal. 27:2062-2068
AIMS Left atrial (LA) stunning, the transient impairment of LA function, is responsible for an increased thrombo-embolic risk after cardioversion of atrial fibrillation (AF). Angiotensin receptor blockers (ARBs) attenuate atrial remodelling in AF and
Autor:
Paulus Kirchhof, Achim Heinecke, Kristina Wasmer, Lars Eckardt, Gerold Mönnig, Dirk Böcker, Günter Breithardt
Publikováno v:
European Heart Journal. 26:1292-1297
Aims External electrical cardioversion is the method of choice to terminate persistent atrial fibrillation. Whether the type of shock electrode affects cardioversion success is not known. We tested whether hand-held steel electrodes improve cardiover
Publikováno v:
European Heart Journal. 16:1943-1951
In order to compare the long-term safety of flecainide and propafenone, an open label, randomized, parallel group study was performed in 335 patients with paroxysmal atrial fibrillation (n = 200) or paroxysmal supraventricular tachycardia (n = 135),
Autor:
J. M. Mencia-Huerta, Annick Ankri, Jacques Maclouf, Gilles Montalescot, Grosgogeat Y, Drobinski G, Daniel Thomas
Publikováno v:
European Heart Journal. 13:1641-1644
Platelet-activating factor (PAF) is involved in experimental models of myocardial ischaemia, and PAF infusion can cause thromboxane release. Thromboxane is produced during brief episodes of reversible myocardial ischaemia in patients with coronary he
Publikováno v:
European Heart Journal. 13:1427-1430
Twenty-four hour Holter monitoring and symptom-limited exercise testing were carried out prior to discharge in 157 patients recovering from acute myocardial infarction. Supraventricular arrhythmias (SVT) during Holter monitoring were recorded in 15%,
Publikováno v:
European heart journal. 23(6)
Background The occurrence of early atrial fibrillation (≤6 months) after ablation of common atrial flutter is of clinical significance. Variables predicting this evolution in ablated patients without a previous atrial fibrillation history have not